Osaic Holdings’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Osaic Holdings’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$98	–	8082
2026 Q1	$98	Buy	+3	New	+$96	﹤0.01%	7630

Other funds holding IBRN

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Osaic Holdings's IBRN Position: Q2 2026 in Review

Osaic Holdings sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q2 2026, closing a stake of 3 shares — an estimated $98 sold.

Osaic Holdings first reported a position in IBRN in Q1 2026 and held it in 1 quarter. The position peaked at $98 in Q1 2026. 5 funds tracked by Wall St. Rank hold IBRN as of Q2 2026.

Osaic Holdings reported no remaining iShares Neuroscience and Healthcare ETF position as of Q2 2026 after selling out during the quarter.
Osaic Holdings sold 3 iShares Neuroscience and Healthcare ETF shares in Q2 2026, an estimated $98.
Osaic Holdings first reported a position in iShares Neuroscience and Healthcare ETF in Q1 2026 and held it in 1 quarter.
Osaic Holdings's iShares Neuroscience and Healthcare ETF position peaked at $98 in Q1 2026.
5 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.